Jaguar health reports 2022 financial results - prescription revenues up 179% to $11.9 million

Prescription product net revenue was approximately $11.9 million for the year ended december 31, 2022 versus approximately $4.3 million for the year ended december 31, 2021, an increase of 178.7%. prescription product net revenue of approximately $3.3 million in q4 2022 increased 3.4% over q3 2022 and increased approximately 57% over prescription product net revenue in q4 2021.
JAGX Ratings Summary
JAGX Quant Ranking